Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women ; volume:7 ; number:1 ; day:25 ; month:11 ; year:2014 ; pages:1 ; date:12.2014
BMC Research Notes / Biomed Central; 7, Heft 1 (25.11.2014), 1, 12.2014
- Creator
-
Ngemu, Erastus K.
Khayeka–Wandabwa, Christopher
Kweka, Eliningaya J.
Choge, Joseph K.
Anino, Edward
Oyoo-Okoth, Elijah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-0500-7-868
- URN
-
urn:nbn:de:101:1-2019112107452256512349
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ngemu, Erastus K.
- Khayeka–Wandabwa, Christopher
- Kweka, Eliningaya J.
- Choge, Joseph K.
- Anino, Edward
- Oyoo-Okoth, Elijah
- SpringerLink (Online service)
Other Objects (12)
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Tolerability of antiretroviral therapy (HAART) in elderly age
High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Universal antiretroviral therapy for pregnant and breastfeeding HIV-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings?
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia
Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children
Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Tolerability of antiretroviral therapy (HAART) in elderly age
High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Universal antiretroviral therapy for pregnant and breastfeeding HIV-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings?
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia
Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children
Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Tolerability of antiretroviral therapy (HAART) in elderly age
High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Universal antiretroviral therapy for pregnant and breastfeeding HIV-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings?
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia
Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children
Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil